Stay updated on Nivolumab in Refractory Biliary Tract Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.

Latest updates to the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page
- Check3 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference1%
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.SummaryDifference2%
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check39 days agoChange DetectedThe page now includes information about the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated to v2.16.1.SummaryDifference2%
- Check67 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check82 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a clinical study involving Nivolumab for biliary tract cancer, while adding references to the study's collaborators and a new version revision.SummaryDifference41%
Stay in the know with updates to Nivolumab in Refractory Biliary Tract Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.